Halix, a contract development and manufacturing organization (CDMO) of clinical and commercial proteins and viral products, based in the Netherlands, said they have met their major milestone with the interim delivery of their new 6,700 square meter cGMP facility in Leiden Bio Science Park.   Following one year of construction, Halix has completed its new state-of-the-art cGMP facility for the development and production of biopharmaceutical drug substances.   The new five-level production facilit...